- Home
- EZGO vs ATOS Comparison
EZGO vs ATOS Comparison
Compare EZGO & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EZGO | ATOS |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 36.2M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | EZGO | ATOS |
|---|---|---|
| Price | $1.32 | $5.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 6.2K | ★ 61.5K |
| Earning Date | 07-01-2025 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,758.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.53 |
| 52 Week High | $2.40 | $7.56 |
Technical Indicators
Market Signals| Indicator | EZGO | ATOS |
|---|---|---|
| Relative Strength Index (RSI) | 53.24 | 57.34 |
| Support Level | $1.16 | $0.66 |
| Resistance Level | $2.11 | $5.56 |
| Average True Range (ATR) | 0.08 | 0.42 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 95.45 | 46.67 |
Price Performance
Historical ComparisonAbout EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.